Published in Hum Mol Genet on May 16, 2007
Telomere diseases. N Engl J Med (2009) 5.68
Telomeres and telomerase in cancer. Carcinogenesis (2009) 4.28
TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am J Hum Genet (2008) 4.12
The telomere syndromes. Nat Rev Genet (2012) 4.01
Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci U S A (2008) 3.86
TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes. Blood (2008) 3.02
Syndromes of telomere shortening. Annu Rev Genomics Hum Genet (2009) 2.60
Dyskeratosis congenita. Hematol Oncol Clin North Am (2009) 2.45
Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita. Proc Natl Acad Sci U S A (2008) 2.37
Human diseases of telomerase dysfunction: insights into tissue aging. Nucleic Acids Res (2007) 2.34
Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations. PLoS One (2010) 2.19
Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells. Blood (2009) 2.12
Telomere maintenance and human bone marrow failure. Blood (2008) 2.09
Advances in the understanding of dyskeratosis congenita. Br J Haematol (2009) 2.05
TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements. Blood (2008) 1.99
Purification of human telomerase complexes identifies factors involved in telomerase biogenesis and telomere length regulation. Mol Cell (2007) 1.87
The genetics and clinical manifestations of telomere biology disorders. Genet Med (2010) 1.83
When ribosomes go bad: diseases of ribosome biogenesis. Mol Biosyst (2010) 1.76
Engineered telomere degradation models dyskeratosis congenita. Genes Dev (2008) 1.72
The telomerase database. Nucleic Acids Res (2007) 1.69
Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1. Blood (2014) 1.64
Dyskeratosis congenita, stem cells and telomeres. Biochim Biophys Acta (2009) 1.62
G-quadruplex nucleic acids and human disease. FEBS J (2010) 1.58
The role of telomere biology in bone marrow failure and other disorders. Mech Ageing Dev (2007) 1.56
Physiological assembly and activity of human telomerase complexes. Mech Ageing Dev (2007) 1.56
Structure of H/ACA RNP protein Nhp2p reveals cis/trans isomerization of a conserved proline at the RNA and Nop10 binding interface. J Mol Biol (2011) 1.53
The genetics of dyskeratosis congenita. Cancer Genet (2011) 1.50
InTERTpreting telomerase structure and function. Nucleic Acids Res (2010) 1.47
Pot1b deletion and telomerase haploinsufficiency in mice initiate an ATR-dependent DNA damage response and elicit phenotypes resembling dyskeratosis congenita. Mol Cell Biol (2008) 1.46
Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening. Nat Genet (2015) 1.46
Telomeres and disease. EMBO J (2009) 1.41
Mutations in C16orf57 and normal-length telomeres unify a subset of patients with dyskeratosis congenita, poikiloderma with neutropenia and Rothmund-Thomson syndrome. Hum Mol Genet (2010) 1.40
Chromosome end maintenance by telomerase. J Biol Chem (2009) 1.36
It all comes together at the ends: telomerase structure, function, and biogenesis. Mutat Res (2011) 1.36
Dyskeratosis congenita. FEBS Lett (2010) 1.36
Dyskeratosis congenita as a disorder of telomere maintenance. Mutat Res (2011) 1.35
Complex inheritance pattern of dyskeratosis congenita in two families with 2 different mutations in the telomerase reverse transcriptase gene. Blood (2007) 1.26
Bone marrow failure and the telomeropathies. Blood (2014) 1.23
Telomeres and immunological diseases of aging. Gerontology (2009) 1.22
Dyskeratosis congenita: the first NIH clinical research workshop. Pediatr Blood Cancer (2009) 1.22
Short telomeres compromise β-cell signaling and survival. PLoS One (2011) 1.17
Structure of a functional ribonucleoprotein pseudouridine synthase bound to a substrate RNA. Nat Struct Mol Biol (2009) 1.17
Differences in disease severity but similar telomere lengths in genetic subgroups of patients with telomerase and shelterin mutations. PLoS One (2011) 1.16
Lung transplantation for pulmonary fibrosis in dyskeratosis congenita: Case Report and systematic literature review. BMC Blood Disord (2011) 1.12
Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy. Transl Res (2013) 1.08
Genomic characterization of the inherited bone marrow failure syndromes. Semin Hematol (2013) 1.07
Hoyeraal-Hreidarsson syndrome caused by a germline mutation in the TEL patch of the telomere protein TPP1. Genes Dev (2014) 1.07
Cell biology of disease: Telomeropathies: an emerging spectrum disorder. J Cell Biol (2014) 1.07
Poly(A)-specific ribonuclease (PARN) mediates 3'-end maturation of the telomerase RNA component. Nat Genet (2015) 1.06
TIN2 protein dyskeratosis congenita missense mutants are defective in association with telomerase. J Biol Chem (2011) 1.04
Characterization of primitive hematopoietic cells from patients with dyskeratosis congenita. Blood (2008) 1.04
Understanding telomere diseases through analysis of patient-derived iPS cells. Curr Opin Genet Dev (2013) 1.03
Telomere and adaptive immunity. Mech Ageing Dev (2007) 1.02
Unraveling the pathogenesis of Hoyeraal-Hreidarsson syndrome, a complex telomere biology disorder. Br J Haematol (2015) 1.01
H/ACA small RNA dysfunctions in disease reveal key roles for noncoding RNA modifications in hematopoietic stem cell differentiation. Cell Rep (2013) 1.01
Ataxia and pancytopenia caused by a mutation in TINF2. Hum Genet (2008) 1.00
Molecular basis of telomere dysfunction in human genetic diseases. Nat Struct Mol Biol (2015) 0.97
Diminished telomeric 3' overhangs are associated with telomere dysfunction in Hoyeraal-Hreidarsson syndrome. PLoS One (2009) 0.96
Do ribosomopathies explain some cases of common variable immunodeficiency? Clin Exp Immunol (2010) 0.95
Stop pulling my strings - what telomeres taught us about the DNA damage response. Nat Rev Mol Cell Biol (2016) 0.93
The short and long telomere syndromes: paired paradigms for molecular medicine. Curr Opin Genet Dev (2015) 0.93
CpG island hypermethylation-associated silencing of small nucleolar RNAs in human cancer. RNA Biol (2012) 0.92
Dyskerin is required for tumor cell growth through mechanisms that are independent of its role in telomerase and only partially related to its function in precursor rRNA processing. Mol Carcinog (2010) 0.92
Dyskeratosis congenita and the DNA damage response. Br J Haematol (2011) 0.92
Evolutionary conservation and expression of human RNA-binding proteins and their role in human genetic disease. Adv Exp Med Biol (2014) 0.92
The molecular genetics of the telomere biology disorders. RNA Biol (2015) 0.91
A TIN2 dyskeratosis congenita mutation causes telomerase-independent telomere shortening in mice. Genes Dev (2014) 0.91
The role of nuclear bodies in gene expression and disease. Biology (Basel) (2013) 0.91
Long-distance placement of substrate RNA by H/ACA proteins. RNA (2008) 0.91
Telomere biology and translational research. Transl Res (2013) 0.90
Genetic interstitial lung disease. Clin Chest Med (2011) 0.89
Telomere dysfunction in human diseases: the long and short of it! Int J Clin Exp Pathol (2009) 0.89
Genetic Variations in Telomere Maintenance, with Implications on Tissue Renewal Capacity and Chronic Disease Pathologies. Curr Pharmacogenomics Person Med (2010) 0.87
The role of telomeres in the ageing of human skin. Exp Dermatol (2011) 0.87
Diagnosis of fanconi anemia by diepoxybutane analysis. Curr Protoc Hum Genet (2015) 0.86
The dyskerin ribonucleoprotein complex as an OCT4/SOX2 coactivator in embryonic stem cells. Elife (2014) 0.85
Loss-of-function mutations in the RNA biogenesis factor NAF1 predispose to pulmonary fibrosis-emphysema. Sci Transl Med (2016) 0.85
Functional and structural impact of target uridine substitutions on the H/ACA ribonucleoprotein particle pseudouridine synthase. Biochemistry (2010) 0.84
DGCR8 Acts as an Adaptor for the Exosome Complex to Degrade Double-Stranded Structured RNAs. Mol Cell (2015) 0.84
The accumulation and not the specific activity of telomerase ribonucleoprotein determines telomere maintenance deficiency in X-linked dyskeratosis congenita. Hum Mol Genet (2011) 0.83
Small RNAs with big implications: new insights into H/ACA snoRNA function and their role in human disease. Wiley Interdiscip Rev RNA (2014) 0.83
Telomere dysfunction in human bone marrow failure syndromes. Nucleus (2011) 0.82
The Shelterin TIN2 Subunit Mediates Recruitment of Telomerase to Telomeres. PLoS Genet (2015) 0.82
Telomere replication: poised but puzzling. J Cell Mol Med (2011) 0.82
Telomere and Telomerase Therapeutics in Cancer. Genes (Basel) (2016) 0.81
POT of gold: modeling dyskeratosis congenita in the mouse. Genes Dev (2008) 0.81
A mutation in the H/ACA box of telomerase RNA component gene (TERC) in a young patient with myelodysplastic syndrome. BMC Med Genet (2014) 0.81
GRIM-1, a novel growth suppressor, inhibits rRNA maturation by suppressing small nucleolar RNAs. PLoS One (2011) 0.80
Insight into the Protein Components of the Box H/ACA RNP. Curr Proteomics (2008) 0.79
Single-molecule analysis of the human telomerase RNA.dyskerin interaction and the effect of dyskeratosis congenita mutations. Biochemistry (2009) 0.78
Telomerase Regulation from Beginning to the End. Genes (Basel) (2016) 0.77
Differential requirements for H/ACA ribonucleoprotein components in cell proliferation and response to DNA damage. Histochem Cell Biol (2015) 0.76
Telomere dynamics in induced pluripotent stem cells: Potentials for human disease modeling. World J Stem Cells (2011) 0.76
Anemia of Central Origin. Semin Hematol (2015) 0.76
Oral Manifestations and Molecular Basis of Oral Genodermatoses: A Review. J Clin Diagn Res (2016) 0.75
The shelterin complex and hematopoiesis. J Clin Invest (2016) 0.75
Multiple Mechanisms Contribute to the Cell Growth Defects Imparted by Human Telomerase Insertion in Fingers Domain Mutations Associated with Premature Aging Diseases. J Biol Chem (2016) 0.75
Telomeres in aging and disease: lessons from zebrafish. Dis Model Mech (2016) 0.75
Control of Cellular Aging, Tissue Function, and Cancer by p53 Downstream of Telomeres. Cold Spring Harb Perspect Med (2017) 0.75
Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet (1996) 39.80
Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res (1988) 32.89
The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature (2001) 7.95
A telomerase component is defective in the human disease dyskeratosis congenita. Nature (1999) 7.91
Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N Engl J Med (2005) 7.09
X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet (1998) 6.82
Small nucleolar RNAs: an abundant group of noncoding RNAs with diverse cellular functions. Cell (2002) 6.62
Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens (1995) 6.33
Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood (2005) 6.05
Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc Natl Acad Sci U S A (2005) 4.64
Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet (2004) 4.63
A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat Genet (2005) 4.57
A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3' end. Mol Cell Biol (1999) 4.51
Biogenesis of small nucleolar ribonucleoproteins. Curr Opin Cell Biol (2002) 4.28
Association between aplastic anaemia and mutations in telomerase RNA. Lancet (2002) 4.02
Dyskeratosis congenita in all its forms. Br J Haematol (2000) 3.89
Beginning to understand the end of the chromosome. Cell (2004) 3.46
Telomerase in the human organism. Oncogene (2002) 3.30
Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Blood (2005) 3.30
Structure and polymorphism of human telomere-associated DNA. Cell (1990) 3.14
Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. Blood Cells Mol Dis (2005) 3.12
Nhp2p and Nop10p are essential for the function of H/ACA snoRNPs. EMBO J (1998) 2.91
The many facets of H/ACA ribonucleoproteins. Chromosoma (2005) 2.89
Human H/ACA small nucleolar RNPs and telomerase share evolutionarily conserved proteins NHP2 and NOP10. Mol Cell Biol (2000) 2.78
Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Mol Dis (2001) 2.69
Stepwise RNP assembly at the site of H/ACA RNA transcription in human cells. J Cell Biol (2006) 2.09
Crystal structure of an H/ACA box ribonucleoprotein particle. Nature (2006) 2.06
Architecture and assembly of mammalian H/ACA small nucleolar and telomerase ribonucleoproteins. EMBO J (2004) 2.04
Crystal structure of a Cbf5-Nop10-Gar1 complex and implications in RNA-guided pseudouridylation and dyskeratosis congenita. Mol Cell (2006) 1.77
Evolutionary appearance of genes encoding proteins associated with box H/ACA snoRNAs: cbf5p in Euglena gracilis, an early diverging eukaryote, and candidate Gar1p and Nop10p homologs in archaebacteria. Nucleic Acids Res (2000) 1.76
In vivo telomere dynamics of human hematopoietic stem cells. Proc Natl Acad Sci U S A (1997) 1.58
Functional characterization of natural telomerase mutations found in patients with hematologic disorders. Blood (2006) 1.57
The Cbf5-Nop10 complex is a molecular bracket that organizes box H/ACA RNPs. Nat Struct Mol Biol (2005) 1.52
Stable expression in yeast of the mature form of human telomerase RNA depends on its association with the box H/ACA small nucleolar RNP proteins Cbf5p, Nhp2p and Nop10p. Nucleic Acids Res (2001) 1.29
Crystal structure determination and site-directed mutagenesis of the Pyrococcus abyssi aCBF5-aNOP10 complex reveal crucial roles of the C-terminal domains of both proteins in H/ACA sRNP activity. Nucleic Acids Res (2006) 1.24
Telomerase RNA deficiency in peripheral blood mononuclear cells in X-linked dyskeratosis congenita. Hum Genet (2004) 1.22
Mutations in telomerase catalytic protein in Japanese children with aplastic anemia. Haematologica (2006) 1.14
Structural study of the H/ACA snoRNP components Nop10p and the 3' hairpin of U65 snoRNA. RNA (2006) 1.00
Single gene disorders or complex traits: lessons from the thalassaemias and other monogenic diseases. BMJ (2000) 1.00
Quantitative reverse transcription-PCR assay of the RNA component of human telomerase using the TaqMan fluorogenic detection system. Clin Chem (1998) 0.96
Expression patterns of WT-1 and Bcr-Abl measured by TaqMan quantitative real-time RT-PCR during follow-up of leukemia patients with the Ph chromosome. Chin Med J (Engl) (2004) 0.85
Progress and prospects in rat genetics: a community view. Nat Genet (2008) 6.01
Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet (2004) 4.63
A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat Genet (2005) 4.57
Association between aplastic anaemia and mutations in telomerase RNA. Lancet (2002) 4.02
Hematopoietic stem cell transplantation: a global perspective. JAMA (2010) 3.63
Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Blood (2005) 3.30
Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol (2009) 3.19
Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. Blood Cells Mol Dis (2005) 3.12
TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes. Blood (2008) 3.02
Inflammatory skin and bowel disease linked to ADAM17 deletion. N Engl J Med (2011) 2.41
Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita. Proc Natl Acad Sci U S A (2008) 2.37
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Biol Blood Marrow Transplant (2011) 2.11
Advances in the understanding of dyskeratosis congenita. Br J Haematol (2009) 2.05
Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome. Blood (2007) 1.93
Functional characterization of novel telomerase RNA (TERC) mutations in patients with diverse clinical and pathological presentations. Haematologica (2007) 1.80
Defining the pathogenic role of telomerase mutations in myelodysplastic syndrome and acute myeloid leukemia. Hum Mutat (2009) 1.78
Constitutional mutations in RTEL1 cause severe dyskeratosis congenita. Am J Hum Genet (2013) 1.71
Aberrant 3' oligoadenylation of spliceosomal U6 small nuclear RNA in poikiloderma with neutropenia. Blood (2012) 1.68
Dyskeratosis congenita, stem cells and telomeres. Biochim Biophys Acta (2009) 1.62
Adhesion of Streptococcus pneumoniae to human airway epithelial cells exposed to urban particulate matter. J Allergy Clin Immunol (2011) 1.60
Heterozygous telomerase RNA mutations found in dyskeratosis congenita and aplastic anemia reduce telomerase activity via haploinsufficiency. Blood (2004) 1.60
Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI. Blood (2013) 1.54
Emberger syndrome-primary lymphedema with myelodysplasia: report of seven new cases. Am J Med Genet A (2010) 1.53
Dyskeratosis congenita: telomerase, telomeres and anticipation. Curr Opin Genet Dev (2005) 1.50
Enhancement of lytic activity of leukemic cells by CD8+ cytotoxic T lymphocytes generated against a WT1 peptide analogue. Leuk Lymphoma (2009) 1.47
Mutations in the telomere capping complex in bone marrow failure and related syndromes. Haematologica (2012) 1.45
Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation. Pediatr Transplant (2007) 1.45
Mutations in C16orf57 and normal-length telomeres unify a subset of patients with dyskeratosis congenita, poikiloderma with neutropenia and Rothmund-Thomson syndrome. Hum Mol Genet (2010) 1.40
Dyskeratosis Congenita: a historical perspective. Mech Ageing Dev (2007) 1.39
The loss of telomerase activity in highly differentiated CD8+CD28-CD27- T cells is associated with decreased Akt (Ser473) phosphorylation. J Immunol (2007) 1.38
Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study. Haematologica (2013) 1.36
Dyskeratosis congenita. Semin Hematol (2006) 1.34
Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors. Blood (2010) 1.33
Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice. Oncogene (2002) 1.31
Dyskeratosis congenita: its link to telomerase and aplastic anaemia. Blood Rev (2003) 1.29
Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups. Haematologica (2012) 1.29
Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors. Haematologica (2010) 1.27
Fanconi anaemia and leukaemia - clinical and molecular aspects. Br J Haematol (2004) 1.26
Inherited aplastic anaemias/bone marrow failure syndromes. Blood Rev (2007) 1.26
The role of the G6PD AEth376G/968C allele in glucose-6-phosphate dehydrogenase deficiency in the seerer population of Senegal. Haematologica (2006) 1.26
Marked genetic heterogeneity in familial myelodysplasia/acute myeloid leukaemia. Br J Haematol (2012) 1.22
Dyskeratosis congenita: a disorder of defective telomere maintenance? Int J Hematol (2005) 1.22
Dyskeratosis congenita: the first NIH clinical research workshop. Pediatr Blood Cancer (2009) 1.22
Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience. Blood (2013) 1.21
Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party. Blood (2012) 1.20
Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation. Blood (2014) 1.20
Poly(A)-specific ribonuclease deficiency impacts telomere biology and causes dyskeratosis congenita. J Clin Invest (2015) 1.16
Differences in disease severity but similar telomere lengths in genetic subgroups of patients with telomerase and shelterin mutations. PLoS One (2011) 1.16
Two brothers with findings resembling congenital intrauterine infection-like syndrome (pseudo-TORCH syndrome). Am J Med Genet A (2003) 1.16
Influence of nucleated cell dose on overall survival of unrelated cord blood transplantation for patients with severe acquired aplastic anemia: a study by eurocord and the aplastic anemia working party of the European group for blood and marrow transplantation. Biol Blood Marrow Transplant (2010) 1.15
Further delineation of the congenital form of X-linked dyskeratosis congenita (Hoyeraal-Hreidarsson syndrome). Eur J Pediatr (2003) 1.11
Inherited bone marrow failure syndromes. Haematologica (2010) 1.09
Revertant somatic mosaicism by mitotic recombination in dyskeratosis congenita. Am J Hum Genet (2012) 1.07
Exogenous TERC alone can enhance proliferative potential, telomerase activity and telomere length in lymphocytes from dyskeratosis congenita patients. Br J Haematol (2008) 1.06
A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with Paroxysmal Nocturnal Haemoglobinuria. BMC Blood Disord (2004) 1.05
Exome sequencing identifies autosomal-dominant SRP72 mutations associated with familial aplasia and myelodysplasia. Am J Hum Genet (2012) 1.05